[1] CLIFFORD V, GONIS G, CRIGHTON G, et al. Investigation for bacterial contamination of blood products implicated in suspected transfusion-transmitted bacterial infection[J].Pathology,2023,55(1):153-155. [2] SMAJJC S C, BECAREVIC M, KLAPIC S, et al. Adverse reactions and complication in voluntary blood donors[J].Mater Sociomed,2023,35(2):98-102. [3] GARRAUD O, HAMZEH-COGNASSE H, CHALAYER E, et al. Platelet transfusion in adults: an update[J].Transfus Clin Biol,2023,30(1):147-165. [4] 滕方, 张燕, 孙桂香,等. 我国三甲医院输血不良反应发生率的Meta分析[J].中国循证医学杂志, 2015, 15(3):1428. [5] ZHOU S, ZHANG X, ZHANG H, et al. Application of the "Plan-Do-Check-Action" plan in improving the pass rate of the "National Medical Licensing Examination"[J].BMC Med Educ,2024,24(1):717. [6] 刘红, 姚健, 林新梅,等. PDCA循环在输血病历检查中的运用[J].重庆医学, 2015, 44(11):113-116. [7] 国家食品药品监督管理局. 药品不良反应报告和监测管理办法[J].中国医药导刊,2004,6(3):221-222. [8] SAMUKANGE W T, LU T A, SOUVEREIN P C, et al. Suspected adverse reactions reported for blood, blood components, and blood products in VigiBase[J].Transfusion,2023,63(5):982-992. [9] CHAVEZ O J, GRIFFIN I, KAZAKOVA S V, et al. Transfusion-related errors and associated adverse reactions and blood product wastage as reported to the National Healthcare Safety Network Hemovigilance Module, 2014-2022[J].Transfusion,2024,64(4):627-637. [10] LIAN B. Adoption of network and plan-do-check-action in the international classification of disease 10 coding[J].World J Clin Cases,2024,12(19):3734-3743. [11] 孙凯洁, 张华宇, 罗涛. 首都医科大学宣武医院全方位PDCA循环在医院绩效考核的实践探索[J].中国医院, 2020, 24(1):211-214. [12] 杨超群, 杜晶. PDCA循环在儿童呼吸内科护理中的应用研究[J].重庆医学, 2021, 50(S01):1213-1215.
2025, Vol. 42 
